Krystal Biotech Inc

Krystal Biotech Inc

KRYS · NASDAQ
KRYS · NASDAQ
302.00
USD6.422.17%

Latest News

    @Reuters
    Reuters

    U.S. FDA approves Krystal Biotech's skin-disorder gene therapy https://t.co/t701bcVfjb https://t.co/3NbhyYTTzN

      @Stocktwits
      Stocktwits

      $KRYS catapulted 121% higher today and cleared $88 to set a new all-time high. https://t.co/Q75hi9dTiF

      Analysts Recommendations

      Bullish

      Buy

      Strong Buy

      Buy

      Hold

      Sell

      Strong Sell

      Day Range

      293.01USD
      305.43USD

      52 Week Range

      184.02USD
      382.54USD

      Market Cap

      9.84BUSD

      lock-imagelock-image

      Get Full Access with Profit PRO

      See which Billionaires own this investment

      About

      General Information

      Type

      Common Stock

      Exchange

      NASDAQ

      Currency Code

      USD

      Currency Name

      US Dollar

      Country Name

      USA

      Country ISO

      US

      ISIN

      US5011471027

      CUSIP

      501147102

      Sector

      Healthcare

      Industry

      Biotechnology

      Fiscal Year End

      December

      IPO date

      -

      Updated At

      -

      Highlights

      PE Ratio

      41.64

      PEG Ratio

      -

      Book Value

      45.92

      Dividend Share

      -

      Dividend Yield

      -

      Earnings Share

      7.98

      Wall Street Target Price

      395.44

      EPS Estimate Current Year

      7.59

      EPS Estimate Next Year

      8.95

      EPS Estimate Current Quarter

      1.9144

      EPS Estimate Next Quarter

      2.1627

      Most Recent Quarter

      -

      Profitability

      Revenue TTM

      440,484,000

      Gross Profit TTM

      416,868,000

      EBITDA

      199,292,992

      Profit Margin

      54.82%

      Return On Assets TTM

      9.37%

      Return On Equity TTM

      20.12%

      Revenue Per Share TTM

      15.076

      Qtly Revenue Growth YOY

      24.10%

      Diluted Eps TTM

      7.98

      Qtly Earnings Growth YOY

      38.80%

      Valuation

      Trailing PE

      41.64

      Forward PE

      47

      Price Sales TTM

      22.3286

      Price Book MRQ

      7.244

      Enterprise Value Revenue

      20

      Enterprise Value EBITDA

      44

      Peers analysis

      • argenx NV ADR
        ARGXargenx NV ADR

        903.08

        3.20%
      • Moderna Inc
        MRNAModerna Inc

        227.40

        2.97%
      • Regeneron Pharmaceuticals Inc
        REGNRegeneron Pharmaceuticals Inc

        965.00

        0.55%
      • UCB SA
        UCBJFUCB SA

        314.92

        0.35%
      • argenx SE
        ARGNFargenx SE

        900.30

        0.00%
      • CSL Limited
        CMXHFCSL Limited

        139.16

        0.00%
      • Vertex Pharmaceuticals Inc
        VRTXVertex Pharmaceuticals Inc

        528.21

        -4.77%
      • Be
        ONCBeiGene, Ltd.

        355.10

        -2.26%
      • CSL Ltd
        CSLLYCSL Ltd

        34.64

        -2.01%
      • UCB SA ADR
        UCBJYUCB SA ADR

        153.70

        -1.47%

      FAQs

      What is Krystal Biotech stock price today?

      What is Krystal Biotech stock ticker?

      Is KRYS stock price going up?

      What is the analyst recommendation for KRYS?

      What is KRYS market cap?

      Does KRYS release financial reports?

      When is KRYS next earnings date?

      What were KRYS Earnings for the last quarter?

      What was KRYS Revenue for the last quarter?

      What was KRYS Net Income for the last quarter?

      Does KRYS pay dividends?

      How many employees does KRYS have?

      What is KRYS EBITDA?

      How to buy KRYS stocks?

      Should I invest in KRYS stock?